Trial intelligence / Profile preview

Postoperative urinary retention after spinal anesthesia with versus without opioid

IRCT20200525047563N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of morphine (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Urinary retention and Complaint of incomplete urination. Started May 2020; status: completed.

02

Drugs

morphine

Beyond the preview

Go deeper on IRCT20200525047563N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200525047563N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call